Six-month outcomes in postapproval HeartMate3 patients: A single-center US experience.
Aditya BansalFaisal AkhtarSapna DesaiCruz Velasco-GonzalezAnirudh BansalAngie TeagleAvni ShridharKaren WebreSheila OstrowDavid FaryPatrick Eugene ParrinoPublished in: Journal of cardiac surgery (2022)
In this single-center study, the real-world 6-month survival in the postapproval group was comparable to the trial results. Further studies are needed to monitor long-term outcomes.